A persistent concern among older adults facing cataract surgery has been whether the procedure might accelerate vision loss from age-related macular degeneration. This worry has led some patients to delay necessary cataract removal, potentially living with preventable visual impairment while fearing worse outcomes for their AMD. The new evidence from JAMA definitively addresses this clinical dilemma with reassuring findings.
Analyzing data from multiple large cohorts, researchers found no statistical association between cataract surgery and progression from dry AMD to the more severe wet form. The study examined thousands of patients with nonneovascular AMD who underwent cataract procedures, tracking their progression rates to neovascular AMD compared to control groups. Importantly, the analysis controlled for age, AMD severity, and other confounding factors that could influence disease progression independently of surgical intervention.
This finding represents crucial clinical guidance for the millions of adults managing both cataracts and AMD simultaneously. Previous smaller studies had suggested potential risks, creating uncertainty in ophthalmology practice about optimal timing for cataract intervention in AMD patients. The robust methodology here provides the statistical power earlier research lacked. For practitioners, this removes a significant clinical hesitation around recommending cataract surgery to AMD patients who would otherwise benefit from improved lens clarity. The implications extend beyond individual treatment decisions to broader healthcare utilization, as delayed cataract surgery often compounds visual disability and reduces quality of life unnecessarily. While patients should still receive individualized risk assessment, this evidence strongly supports that cataract surgery can proceed based on visual needs rather than unfounded AMD progression fears.